American Century Companies’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
BCM
American Century Companies's INO Position: Q3 2025 in Review
American Century Companies sold out of Inovio Pharmaceuticals (INO) in Q3 2025, closing a stake of 42,917 shares — an estimated $87.3K sold.
American Century Companies first reported a position in INO in Q4 2015 and held it in 13 quarters. The position peaked at $1.31M in Q1 2016. 99 funds tracked by Wall St. Rank hold INO as of Q3 2025.
- American Century Companies reported no remaining Inovio Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
- American Century Companies sold 42,917 Inovio Pharmaceuticals shares in Q3 2025, an estimated $87.3K.
- American Century Companies first reported a position in Inovio Pharmaceuticals in Q4 2015 and held it in 13 quarters.
- American Century Companies's Inovio Pharmaceuticals position peaked at $1.31M in Q1 2016.
- 99 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2025.
Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.